LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,245,198 | +202.4% | 20,781 | +263.8% | 0.00% | +100.0% |
| Q2 2023 | $411,835 | -48.3% | 5,712 | -47.3% | 0.00% | 0.0% |
| Q1 2023 | $797,023 | +213.0% | 10,835 | +184.2% | 0.00% | – |
| Q4 2022 | $254,642 | -100.0% | 3,812 | -77.4% | 0.00% | -100.0% |
| Q3 2022 | $1,453,020,000 | +280.4% | 16,874 | +294.2% | 0.00% | +100.0% |
| Q2 2022 | $381,951,000 | -32.7% | 4,281 | -15.1% | 0.00% | 0.0% |
| Q1 2022 | $567,287,000 | -64.0% | 5,043 | -50.6% | 0.00% | -50.0% |
| Q4 2021 | $1,576,573,000 | -34.8% | 10,207 | -41.2% | 0.00% | -33.3% |
| Q3 2021 | $2,416,645,000 | +476.7% | 17,346 | +443.1% | 0.00% | +200.0% |
| Q2 2021 | $419,021,000 | -26.4% | 3,194 | -14.5% | 0.00% | 0.0% |
| Q1 2021 | $569,706,000 | +164.0% | 3,737 | +72.2% | 0.00% | – |
| Q4 2020 | $215,806,000 | +5.0% | 2,170 | +0.6% | 0.00% | – |
| Q3 2020 | $205,510,000 | -36.9% | 2,156 | -25.9% | 0.00% | -100.0% |
| Q2 2020 | $325,595,000 | -69.8% | 2,911 | -80.4% | 0.00% | -50.0% |
| Q1 2020 | $1,078,292,000 | +211.6% | 14,828 | +346.9% | 0.00% | +100.0% |
| Q4 2019 | $346,034,000 | -1.9% | 3,318 | -6.4% | 0.00% | 0.0% |
| Q3 2019 | $352,670,000 | +40.4% | 3,543 | +61.0% | 0.00% | 0.0% |
| Q2 2019 | $251,244,000 | -54.6% | 2,201 | -50.0% | 0.00% | 0.0% |
| Q1 2019 | $552,998,000 | +217.4% | 4,399 | +242.6% | 0.00% | – |
| Q4 2018 | $174,239,000 | -82.6% | 1,284 | -64.8% | 0.00% | -100.0% |
| Q3 2018 | $1,002,163,000 | +113.1% | 3,651 | +60.8% | 0.00% | 0.0% |
| Q2 2018 | $470,276,000 | -57.6% | 2,270 | -66.2% | 0.00% | -50.0% |
| Q1 2018 | $1,110,040,000 | -6.0% | 6,721 | -22.0% | 0.00% | 0.0% |
| Q4 2017 | $1,180,610,000 | -20.0% | 8,622 | -20.5% | 0.00% | -50.0% |
| Q3 2017 | $1,476,411,000 | +97.3% | 10,844 | +76.0% | 0.00% | +100.0% |
| Q2 2017 | $748,188,000 | +2.1% | 6,163 | -10.5% | 0.00% | 0.0% |
| Q1 2017 | $732,729,000 | +16.7% | 6,883 | +13.8% | 0.00% | -33.3% |
| Q4 2016 | $628,012,000 | +103.9% | 6,046 | +100.3% | 0.00% | +200.0% |
| Q3 2016 | $308,017,000 | -56.4% | 3,018 | -49.0% | 0.00% | -66.7% |
| Q2 2016 | $706,078,000 | +161.6% | 5,920 | +134.9% | 0.00% | +200.0% |
| Q1 2016 | $269,867,000 | -48.2% | 2,520 | -47.5% | 0.00% | 0.0% |
| Q4 2015 | $520,632,000 | +71.3% | 4,802 | +35.3% | 0.00% | 0.0% |
| Q3 2015 | $303,886,000 | +106.3% | 3,548 | +143.0% | 0.00% | – |
| Q2 2015 | $147,314,000 | +310.0% | 1,460 | +213.3% | 0.00% | – |
| Q1 2015 | $35,933,000 | -86.2% | 466 | -91.6% | 0.00% | – |
| Q3 2014 | $260,231,000 | +17306.8% | 5,538 | +22975.0% | 0.00% | – |
| Q2 2014 | $1,495,000 | -87.6% | 24 | -89.6% | 0.00% | – |
| Q4 2013 | $12,098,000 | -94.2% | 230 | -95.2% | 0.00% | – |
| Q3 2013 | $207,181,000 | -10.3% | 4,787 | -22.5% | 0.00% | – |
| Q2 2013 | $231,068,000 | – | 6,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |